No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Adjustable Lens Customizable After Cataract Surgery Is Now Offered at Northwell Health

Editor: What To Know

  • The patient must wear special eyeglasses for UV protection from the time of the cataract surgery to the end of the light treatments to protect the new lens from UV light in the environment.
  • “Small variations in healing happen in most eyes and with the Light Adjustable Lens, we gain the ability to correct even small amounts of nearsightedness, farsightedness and astigmatism,” said Scott Sheren, MD, director of ophthalmology at Northwell Health Eye Institute at Riverhead.
  • A cataract is a cloudy area in the lens of the eye that leads to a decrease in vision.

The latest development in cataract surgery is now available at several Northwell locations including Peconic Bay Medical Center, Syosset Surgical center and Manhattan Eye, Ear, and Throat Hospital. The cutting-edge Light Adjustable Lens (LAL) enables patients and their doctor to design, trial and customize vision after cataract surgery, more often giving patients their very best possible vision without eyeglasses after surgery.

A cataract is a cloudy area in the lens of the eye that leads to a decrease in vision. Cataracts often develop slowly and can affect one or both eyes. Symptoms may include faded colors, blurry or double vision, halos around light, trouble with bright lights, and trouble seeing at night.

“RxSight’s Light Adjustable Lens allows ophthalmologists to give cataract patients even more precise visual outcomes than ever before,” said Richard Braunstein, MD, senior vice president and executive director of ophthalmology at Northwell Health. “We’re always striving to provide the best care possible for our patients, and with this new technology we are living up to that goal.”

The intraocular lens is made of a unique material that reacts to UV light, which is delivered by the Light Delivery Device, as soon as 17 days after surgery. Patients receive three to five light treatments over a period of several weeks, each lasting about 40-150 seconds, depending upon the amount of adjustment needed. The patient must wear special eyeglasses for UV protection from the time of the cataract surgery to the end of the light treatments to protect the new lens from UV light in the environment.

“Small variations in healing happen in most eyes and with the Light Adjustable Lens, we gain the ability to correct even small amounts of nearsightedness, farsightedness and astigmatism,” said Scott Sheren, MD, director of ophthalmology at Northwell Health Eye Institute at Riverhead. “This lens is amazing because you can adjust its shape and thus its power in the eye and this is done without the use of a laser or conventional surgery.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy